0. DOCID:22852 SCORE: 0.00444774122475374
DOCNO: 7773901
AUTHOR: A Mullens A
PUBTYPE: Journal Article
JOURNALTITLE: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
COUNTRY: CANADA
TITLE: The Dutch experience with euthanasia: lessons for Canada?
PUBDATE: 19950601
Anne Mullens used a recent fellowship provided by the Atkinson Foundation to take an in-depth look at euthanasia in the Netherlands. During her time in Holland, she discussed the issue with doctors who support and oppose euthanasia. She accompanied a doctor as he visited a patient who was dying of cancer and was beginning to consider the possibility of euthanasia. She talked to a nonphysician who is adamantly opposed to euthanasia and carries a card stating that. She visited a hospital in Amsterdam that has received requests from foreigners seeking euthansia. Mullens offers a comprehensive look at an issue that continues to provoke strong feelings among Canadian physicians and patients.


1. DOCID:22851 SCORE: 0.00444774103293839
DOCNO: 8844291
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Kidney Pelvis
DESCRIPTOR: Neoplasms, Multiple Primary
QUALIFIER: diagnosis
QUALIFIER: diagnosis
QUALIFIER: diagnosis
QUALIFIER: diagnosis
AUTHOR: M Ando M
AUTHOR: C Arisawa C
AUTHOR: T Okano T
AFFILIATION: Department of Urology, East Tokyo Metropolitan Hospital, Japan.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: International journal of urology : official journal of the Japanese Urological Association.
COUNTRY: JAPAN
TITLE: A case of renal cell carcinoma associated with synchronous contralateral renal pelvic cancer and bladder tumor.
PUBDATE: 19960701
We report a case of renal cell carcinoma associated with synchronous contralateral renal pelvic cancer and bladder tumor. The patient underwent total nephroureterectomy for the left renal pelvic cancer with transurethral resection of the bladder tumor. After 2 courses of combination chemotherapy, we performed surgical enucleation of the right renal cell carcinoma. Although transurethral resection of the recurrent bladder tumors was undergone 17 months after the last operation, the patient retains normal renal function.


2. DOCID:22825 SCORE: 0.00444774065645133
DOCNO: 7774494
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: analysis
AUTHOR: A W Martin AW
AUTHOR: D D Davey DD
AFFILIATION: Department of Pathology, University of Louisville School of Medicine, KY, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Diagnostic cytopathology.
COUNTRY: UNITED STATES
TITLE: Comparison of immunoreactivity of neu oncoprotein in fine-needle aspirates and paraffin-embedded materials.
PUBDATE: 19950301
Expression of the neu oncogene has been extensively examined in frozen and paraffin section breast cancers; however, very few studies examine neu oncoprotein oncoprotein expression in fine-needle aspirates. To this effect, we compared the expression of neu oncoprotein in formalin-fixed paraffin-embedded breast cancers and the corresponding fine-needle aspirates of these cancers. There was 100% correlation between the expression of neu oncoprotein in the paraffin-embedded breast cancers and the fine-needle aspirates, indicating the suitability of fine-needle aspirates for the expression of neu oncoprotein in breast cancers.


3. DOCID:21442 SCORE: 0.00192337548484798
DOCNO: 8854414
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Mass Screening
DESCRIPTOR: Patient Education
QUALIFIER: prevention & control
AUTHOR: A Boyden A
AFFILIATION: Public Health Branch, Dept. of Human Services, Victoria.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Australian family physician.
COUNTRY: AUSTRALIA
TITLE: Prostate cancer screening: what general practitioners and patients need to know.
PUBDATE: 19960901
Much controversy surrounds the appropriateness of screening for prostate cancer. The individual benefit from screening is unproven. Screening may result in many men being unnecessarily treated for prostate cancer with the associated risks of developing treatment related side effects, including impotence and incontinence. Men requesting screening need to be informed of these issues before they decide whether to proceed. This article reviews the current position in relation to screening, critically appraising current thinking in order to clarify the issues.


4. DOCID:22400 SCORE: 0.00171176344735501
DOCNO: 7529813
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Home Care Services
DESCRIPTOR: Palliative Care
QUALIFIER: therapeutic use
QUALIFIER: complications
QUALIFIER: drug therapy
QUALIFIER: complications
AUTHOR: S Mercadante S
AUTHOR: M T Simonetti MT
AFFILIATION: Department of Anesthesia and Intensive Care, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Journal of pain and symptom management.
COUNTRY: UNITED STATES
TITLE: Dobutamine as palliative drug in home-care advanced cancer patients.
PUBDATE: 19941001
We describe a patient with advanced cancer whose severe symptoms of congestive heart failure were successfully treated with dobutamine. The intermittent intravenous administration of dobutamine 5 micrograms/kg/min for 3 hr per day at home enabled control of dyspnea, leg edema, and pain, and increased urine output after 1 day. An improvement in renal function was observed in the following days. The mechanism and the utility of a palliative approach with dobutamine are discussed.


5. DOCID:23280 SCORE: 0.00141672574992045
DOCNO: 7816223
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: prevention & control
AUTHOR: P Greenwald P
AFFILIATION: Division of Cancer Prevention and Control, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Military medicine.
COUNTRY: UNITED STATES
TITLE: Chemoprevention research at the U.S. National Cancer Institute.
PUBDATE: 19940701
The use of specific chemicals to prevent the development or retard the progression of carcinogenesis--known as chemoprevention--is a rapidly growing area in cancer research. Developed through the integration of strong laboratory and epidemiologic evidence, chemoprevention research has moved successfully into the clinical research setting, with diverse agents being tested for their efficacy in individuals at high risk of developing certain cancers. The public health potential for reducing cancer incidence and mortality through chemical intervention provides a unique and promising opportunity, and continued support of this multidisciplinary approach to cancer prevention remains a high priority for the U.S. National Cancer Institute.


6. DOCID:20081 SCORE: 0.00115687662985939
DOCNO: 8795566
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: organization & administration
QUALIFIER: therapy
QUALIFIER: organization & administration
AUTHOR: D J Kerr DJ
AUTHOR: R Griffiths R
AUTHOR: B Edwards B
PUBTYPE: Editorial
JOURNALTITLE: British journal of cancer.
COUNTRY: SCOTLAND
TITLE: Delivering cancer care: a model from the West Midlands.
PUBDATE: 19960901
It would seem that time, tide and wind are favourably set for a shift in the organisation of cancer services. Let us test the hypotheses outlined in this brief paper and see if these changes will bring about demonstrable benefit.


7. DOCID:23167 SCORE: 0.00112224614089406
DOCNO: 8591642
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Neoplasms, Radiation-Induced
QUALIFIER: etiology
QUALIFIER: etiology
AUTHOR: R N Visweswara RN
AUTHOR: M H Patel MH
AFFILIATION: Department of Pathology, Al-Arab Medical University, Benghazi, Libya.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: The Central African journal of medicine.
COUNTRY: ZIMBABWE
TITLE: Branchiogenic carcinoma--a case for radiation induced carcinogenesis.
PUBDATE: 19950901
From the time the first case of bronchial cleft carcinoma was reported over a century ago, very few cases have been reported which prove to be a cancer of primary branchial origin, while many metastatic cystic squamous cell carcinomas in the neck have been wrongly categorized as branchial carcinoma. Here, we describe a case of primary branchiogenic carcinoma in a 53 year old Libyan female showing a transformation of a benign epithelium into a malignant type. We further report that this transformation is perhaps brought about by an irregular radiotherapy to the head and neck region.


8. DOCID:23632 SCORE: 0.00112125617633326
DOCNO: 8792623
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: chemistry
QUALIFIER: drug effects
QUALIFIER: chemistry
AUTHOR: T C McKee TC
AUTHOR: R W Fuller RW
AUTHOR: C D Covington CD
AUTHOR: J H Cardellina JH
AUTHOR: R J Gulakowski RJ
AUTHOR: B L Krepps BL
AUTHOR: J B McMahon JB
AUTHOR: M R Boyd MR
AFFILIATION: Division of Cancer Treatment, Diagnosis and Centers, National Cancer Institute, NCI-FCRDC, Frederick, Maryland 21702-1201, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Journal of natural products.
COUNTRY: UNITED STATES
TITLE: New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii.
PUBDATE: 19960801
During a chemotaxonomic survey of Calophyllum extracts present in the National Cancer Institute's natural product repository, four new pyranocoumarins were isolated from extracts of C. lanigerum var. austrocoriaceum and C. teysmannii var. inophylloide (King.) P. F. Stevens (Clusiaceae). The structure elucidation and anti-HIV activity of calanolide E2 (4), cordatolide E (5), pseudocordatolide C (6), and calanolide F (9), along with a simple prenylated coumarin precursor (11), are described here.


9. DOCID:23194 SCORE: 0.00112065506469894
DOCNO: 8052876
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
QUALIFIER: administration & dosage
QUALIFIER: drug therapy
AUTHOR: N van Zandwijk N
AUTHOR: O Dalesio O
AFFILIATION: Department of Pulmonary Oncology, The Netherlands Cancer Institute, Amsterdam.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Seminars in oncology.
COUNTRY: UNITED STATES
TITLE: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer.
PUBDATE: 19940601
The history of chemotherapy for non-small cell lung carcinoma is one of very slow progress. Consequently, the categories of patients who will ultimately benefit from this modality are still debated. Recent European Organization for Research and Treatment of Cancer studies show that there is less concern about the importance of platinum as an ingredient of combination regimens or as an adjunct to radiotherapy. The presence of cisplatin is related to better response and survival in patients with locoregional and distant metastatic disease.


10. DOCID:22610 SCORE: 0.000893282901171368
DOCNO: 9415337
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: metabolism
QUALIFIER: radiotherapy
QUALIFIER: metabolism
QUALIFIER: metabolism
QUALIFIER: metabolism
AUTHOR: J B Epstein JB
AUTHOR: S Emerton S
AUTHOR: A Guglietta A
AUTHOR: N Le N
AFFILIATION: British Columbia Cancer Agency, Vancouver, Canada.
PUBTYPE: Journal Article
JOURNALTITLE: Oral oncology.
COUNTRY: ENGLAND
TITLE: Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer.
PUBDATE: 19970901
Biological response modifiers have been studied in animal models of oral mucositis. We assessed the presence of epidermal growth factor (EGF) in patients during radiation therapy for head and neck cancer. The findings of this preliminary study showed that it is possible to measure the presence of EGF in oral secretions during radiation therapy. EGF was shown to decrease during the course of radiation therapy, and a trend was seen with decreasing EGF and increasing oral ulceration (P = 0.10) and increasing total mucositis score (P = 0.09).


11. DOCID:22071 SCORE: 0.000826541870040805
DOCNO: 7570587
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: drug therapy
QUALIFIER: drug therapy
QUALIFIER: drug therapy
AUTHOR: S Okuyama S
AFFILIATION: Department of Radiology, Tohoku Rosai Hospital, Sendai.
PUBTYPE: Journal Article
JOURNALTITLE: The Tohoku journal of experimental medicine.
COUNTRY: JAPAN
TITLE: Antibiotic pasting for foul putrefactive cancers.
PUBDATE: 19950401
Putrefaction of cancers in infrequent. Nonetheless, it presents a difficult clinical problem of foulness. We prepared 5% antibiotic pastes by adding sodium polyacrylate to aliquots of antibiotic solutions, and applied them to putrefactive lesions in 4 cases of rectal cancer, 2 of breast cancer and 1 of tongue cancer. The putrefaction was promptly brought under control in all of them, permitting an improved QOL. Concomitant application of anticancer pastes was also found remarkably effective. Use of sulperazone may offer a better chance of overcoming the beta lactamase barrier in cases of prolonged use.


12. DOCID:23439 SCORE: 0.000826536124229471
DOCNO: 8533691
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: etiology
QUALIFIER: complications
QUALIFIER: etiology
AUTHOR: K Takei K
AUTHOR: H Ito H
AUTHOR: M Masai M
AUTHOR: T Kotake T
AUTHOR: Y Ishida Y
AUTHOR: K Nagao K
AFFILIATION: Department of Urology, Ichihara Hospital, Teikyo University School of Medicine.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Hinyokika kiyo. Acta urologica Japonica.
COUNTRY: JAPAN
TITLE: [A case of leiomyosarcoma of the diverticulum of urinary bladder]
PUBDATE: 19951101
A 77-year-old man was admitted to our hospital complaining of gross hematuria. Cystoscopy showed an approximately 4-cm non-papillary tumor in and out of the diverticulum of the left posterior wall. Total cystectomy was performed. Histopathological diagnosis was pleomorphic leiomyosarcoma. According to TNM classification of bladder cancer, the stage of this tumor was pT3bpN0M0. The patient had local recurrence two months after the operation, and died a month later. This is the second case of leiomyosarcoma of the diverticulum of urinary bladder reported in Japan.


13. DOCID:21884 SCORE: 0.000826421717768755
DOCNO: 7756125
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Family
QUALIFIER: genetics
QUALIFIER: genetics
QUALIFIER: genetics
QUALIFIER: genetics
QUALIFIER: genetics
QUALIFIER: genetics
AUTHOR: V Bataille V
AUTHOR: R Hiles R
AUTHOR: J A Bishop JA
AFFILIATION: ICRF Skin Tumour Laboratory, Dermatology Department, Royal London Hospital, London, U.K.
PUBTYPE: Journal Article
JOURNALTITLE: The British journal of dermatology.
COUNTRY: ENGLAND
TITLE: Retinoblastoma, melanoma and the atypical mole syndrome.
PUBDATE: 19950101
Retinoblastoma patients and their relatives appear to have an increased risk of other cancers, especially melanoma, which represents 7% of second primaries in retinoblastoma survivors. Individuals belonging to families with the atypical mole syndrome (another family cancer syndrome with a genetic susceptibility to melanoma) have a recognizable phenotype, with many atypical melanocytic naevi. We report two families in which both retinoblastoma and melanoma occurred. It is of interest that in these families atypical melanocytic naevi were also demonstrated.


14. DOCID:21863 SCORE: 0.000826081312386838
DOCNO: 8782803
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Attitude to Health
DESCRIPTOR: Ethnic Groups
QUALIFIER: methods
QUALIFIER: psychology
AUTHOR: N Pfeffer N
AUTHOR: C Moynihan C
AFFILIATION: City & Hackney Health Council, Royal Marsden Hospital.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: The British journal of cancer. Supplement.
COUNTRY: ENGLAND
TITLE: Ethnicity and health beliefs with respect to cancer: a critical review of methodology.
PUBDATE: 19960901
This paper considers methodological issues raised by investigations into the relationship between health beliefs with respect to cancer and ethnicity. Because what people will proffer in response to a question about their health beliefs and ethnicity depends amongst other things, on the time and place of asking, and the identity, purpose and methodological approach of the person posing the question, we have focused exclusively on British material; also the practical issues discussed are largely relevant to Britain only.